Nomura Raises PHARMARON TP to HKD32.2 on Higher FY Revenue Forecast Driven by Order BacklogAASTOCKS News·Jul 27 at 02:12 AM03759-2.84%300759-3.25%
Pharmaron Unveils 2026 H Share Incentive Plan and Governance OverhaulTip Ranks·Jul 24 at 06:09 AM03759-2.84%300759-3.25%
Global Supply Chains and Overseas Expansion: How Hong Kong Equities Navigate Downside Macro RisksGlobal Report·Jul 22 at 04:18 AM02050-3.05%03200-10.99%
Pharmaron Beijing files HKEX next-day disclosure return reporting 5,396,470 new H shares issuedPUBT·Jul 22 at 03:40 AM03759-2.84%300759-3.25%
HSBC Research Keeps PHARMARON at Buy, Expects Strong CDMO Growth to Offset FX PressureAASTOCKS News·Jul 15 at 09:40 PM300759-3.25%03759-2.84%
Daiwa Remains a Buy on Pharmaron Beijing Co., Ltd. Class H (17Q1)Tip Ranks·Jul 15 at 07:26 PM300759-3.25%03759-2.84%
Pharmaron Hong Kong rises over 10% on profit outlookHK Stock Market Update·Jul 15 at 12:10 AM03759-2.84%
Pharmaron HK climbs 8% on profit forecast, new orders surgeHK Stock Market Update·Jul 14 at 09:40 PM03759-2.84%
Strategic Repositioning: Capital Pivots to Yield and Healthcare Supply Chains in AsiaGlobal Report·Jul 14 at 06:47 AM03759-2.84%05951
UBS' Investment Ratings and TPs on CRO Stocks (Table)AASTOCKS News·Jul 14 at 02:00 AM300759-3.25%02268-3.68%
PHARMARON Expects Interim Net Profit to Rise Up to 10% YoYAASTOCKS News·Jul 13 at 09:16 PM300759-3.25%03759-2.84%
Pharmaron HK Tumbles on Profit Warning, Down 1.4%HK Stock Market Update·Jul 13 at 09:10 PM03759-2.84%
Pharmaron Forecasts Double-Digit Revenue Growth for Interim 2026 ResultsTip Ranks·Jul 13 at 08:08 AM300759-3.25%03759-2.84%
The Value Chain Inversion of Pharma R&D: How Hong Kong CXOs Are Becoming PlatformsGlobal Report·Jul 11 at 04:13 AM02359-0.57%03347-3.37%